Gene · 1286
Papers1,462
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,462
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multidisciplinary management improves the genetic diagnosis of hereditary kidney diseases in the next generation sequencing (NGS) era. | Nefrologia (Engl Ed) | 2024 | 38418364 | PubTator, text mining | PubMed |
| A Deeper Insight into COL4A3, COL4A4, and COL4A5 Variants and Genotype-Phenotype Correlation of a Turkish Cohort with Alport Syndrome. | Mol Syndromol | 2024 | 38357258 | PubTator, text mining | PubMed |
| Increased prevalence of kidney cysts in individuals carrying heterozygous COL4A3 or COL4A4 pathogenic variants. | Nephrol Dial Transplant | 2024 | 38317457 | PubTator, text mining | PubMed |
Whole-Exome Screening and Analysis of Signaling Pathways in Multiple Endocrine Neoplasia Type 1 Patients with Different Outcomes: Insights into Cellular Mechanisms and Possible Functional Implications. | Int J Mol Sci | 2024 | 38256138 | PubTator, text mining | PubMed |
| Single variant, yet "double trouble": TSC and KBG syndrome because of a large de novo inversion. | Life Sci Alliance | 2024 | 38253421 | PubTator, text mining | PubMed |
| Neutrophil-mediated type IV collagen degradation is elevated in patients with mild endoscopic ulcerative colitis reflecting early mucosal destruction. | Sci Rep | 2024 | 38238446 | PubTator, text mining | PubMed |
| The multifaceted roles of COL4A4 in lung adenocarcinoma: An integrated bioinformatics and experimental study. | Comput Biol Med | 2024 | 38217972 | PubTator, text mining | PubMed |
| Is there a dominant-negative effect in individuals with heterozygous disease-causing variants in COL4A3/COL4A4? | Clin Genet | 2024 | 38214412 | PubTator, text mining | PubMed |
| Frail inner limiting membrane maculopathy suggested to describe a new retinal Alport-like condition with two variants in three generations of females. | Ophthalmic Genet | 2024 | 38197426 | PubTator, text mining | PubMed |
| Replacing a kidney biopsy by exome sequencing in undetermined kidney diseases-not yet ready for prime time! | Clin Kidney J | 2024 | 38186890 | PubTator, text mining | PubMed |
| Beyond the kidney biopsy: genomic approach to undetermined kidney diseases. | Clin Kidney J | 2024 | 38186885 | PubTator, text mining | PubMed |
| Novel Digenic Variants in COL4A4 and COL4A5 Causing X-Linked Alport Syndrome: A Case Report. | Case Rep Nephrol Dial | 2024 | 38179179 | PubTator, text mining | PubMed |
| Cystic phenotype and chronic kidney disease in autosomal dominant Alport syndrome. | Nephrol Dial Transplant | 2024 | 38178635 | PubTator, text mining | PubMed |
| PANoptosis-like death in acute-on-chronic liver failure injury. | Sci Rep | 2024 | 38172209 | PubTator, text mining | PubMed |
| Identification of hub genes distinguishing subtypes in endometrial stromal sarcoma through comprehensive bioinformatics analysis. | Sci Rep | 2024 | 38167455 | PubTator, text mining | PubMed |
| Flow induces common and specific transcriptional changes in renal tubular epithelial cells involving the PI3K pathway. | FASEB J | 2024 | 38050412 | PubTator, text mining | PubMed |
| The VUS Challenge in Cystic Kidney Disease: A Case-Based Review. | Kidney360 | 2024 | 37962562 | PubTator, text mining | PubMed |
| Ocular manifestations of the genetic causes of focal and segmental glomerulosclerosis. | Pediatr Nephrol | 2024 | 37578539 | PubTator, text mining | PubMed |
| Exploring Omega-3's Impact on the Expression of Bone-Related Genes in Meagre (Argyrosomus regius). | Biomolecules | 2023 | 38254657 | PubTator, text mining | PubMed |
| Congenital anomalies of lens shape. | Taiwan J Ophthalmol | 2023 | 38249493 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1286/papers?page=9